Viking Therapeutics (VKTX) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free VKTX Stock Alerts $68.86 +3.79 (+5.82%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Viking Therapeutics Short Interest DataCurrent Short Volume11,150,000 sharesPrevious Short Volume9,520,000 sharesChange Vs. Previous Month+17.12%Dollar Volume Sold Short$746.49 millionShort Interest Ratio / Days to Cover1.8Last Record DateApril 15, 2024Outstanding Shares110,220,000 sharesPercentage of Shares Shorted10.12%Today's Trading Volume3,519,010 sharesAverage Trading Volume5,626,465 sharesToday's Volume Vs. Average63% Short Selling Viking Therapeutics ? Sign up to receive the latest short interest report for Viking Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVKTX Short Interest Over TimeVKTX Days to Cover Over TimeVKTX Percentage of Float Shorted Over Time Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Viking Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202411,150,000 shares $746.49 million +17.1%N/A1.8 $66.95 3/31/20249,520,000 shares $780.64 million -14.5%N/A1.5 $82.00 3/15/202411,140,000 shares $696.92 million -9.3%N/A1.8 $62.56 2/29/202412,280,000 shares $946.17 million +2.2%N/A2.2 $77.05 2/15/202412,020,000 shares $382.84 million -7.0%N/A3 $31.85 1/31/202412,920,000 shares $311.89 million -5.8%N/A4.6 $24.14 Get the Latest News and Ratings for VKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202413,710,000 shares $293.94 million +1.9%N/A5.3 $21.44 12/31/202313,460,000 shares $250.49 million -7.8%N/A5.3 $18.61 12/15/202314,600,000 shares $275.94 million -5.3%N/A5.9 $18.90 11/30/202315,420,000 shares $188.43 million -9.1%N/A6.4 $12.22 11/15/202316,970,000 shares $187.18 million +3.4%N/A8.5 $11.03 10/31/202316,420,000 shares $161.08 million +11.0%N/A8.6 $9.81 10/15/202314,800,000 shares $162.06 million +6.6%N/A7.7 $10.95 9/30/202313,890,000 shares $153.76 million +1.8%N/A7.8 $11.07 9/15/202313,640,000 shares $201.46 million +5.7%N/A6.6 $14.77 8/31/202312,910,000 shares $178.29 million -5.0%N/A5.6 $13.81 8/15/202313,590,000 shares $201.27 million +14.8%N/A5.5 $14.81 7/31/202311,840,000 shares $171.68 million -2.7%N/A4.2 $14.50 7/15/202312,170,000 shares $189.61 million +0.7%N/A4 $15.58 6/30/202312,090,000 shares $195.98 million +9.2%N/A3.6 $16.21 6/15/202311,070,000 shares $248.63 million -6.9%N/A2.2 $22.46 5/31/202311,890,000 shares $261.10 million -1.2%N/A2.5 $21.96 5/15/202312,030,000 shares $264.54 million +3.8%N/A2.5 $21.99 4/30/202311,590,000 shares $246.98 million +1.3%N/A2.6 $21.31 4/15/202311,440,000 shares $214.50 million +1.6%N/A2.7 $18.75 3/31/202311,260,000 shares $187.48 million +112.1%N/A2.9 $16.65 3/15/20235,310,000 shares $56.71 million +9.5%7.8%1.8 $10.68 2/28/20234,850,000 shares $53.40 million +4.1%7.1%1.3 $11.01 2/15/20234,660,000 shares $51.91 million +17.7%6.9%1.3 $11.14 1/31/20233,960,000 shares $34.69 million -33.2%5.9%1.1 $8.76 1/15/20235,930,000 shares $53.07 million +4.2%8.9%1.7 $8.95 12/30/20225,690,000 shares $53.49 million +201.1%8.4%1.7 $9.40 12/15/20221,890,000 shares $7.28 million +6.8%2.8%0.6 $3.85 11/30/20221,770,000 shares $7.17 million -1.7%2.6%2.3 $4.05 11/15/20221,800,000 shares $8.05 million -5.3%2.7%2.4 $4.47 10/31/20221,900,000 shares $7.79 million +6.2%2.8%2.9 $4.10 10/15/20221,790,000 shares $5.85 million -4.8%2.7%2.6 $3.27 9/30/20221,880,000 shares $5.11 million -2.6%2.8%3 $2.72 9/15/20221,930,000 shares $6.41 million -4.5%2.8%2.2 $3.32 8/31/20222,020,000 shares $6.42 million -3.4%3.0%2.1 $3.18“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). VKTX Short Interest - Frequently Asked Questions What is Viking Therapeutics' current short interest? Short interest is the volume of Viking Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 11,150,000 shares of VKTX short. Learn More on Viking Therapeutics' current short interest. What is a good short interest ratio for Viking Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VKTX shares currently have a short interest ratio of 2.0. Learn More on Viking Therapeutics's short interest ratio. Which institutional investors are shorting Viking Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Viking Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Viking Therapeutics' short interest increasing or decreasing? Viking Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 11,150,000 shares, an increase of 17.1% from the previous total of 9,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Viking Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Viking Therapeutics: Intra-Cellular Therapies, Inc. (3.71%), Jazz Pharmaceuticals plc (6.14%), Cytokinetics, Incorporated (13.91%), Cerevel Therapeutics Holdings, Inc. (9.10%), Elanco Animal Health Incorporated (3.14%), Ionis Pharmaceuticals, Inc. (7.12%), Ascendis Pharma A/S (6.18%), Apellis Pharmaceuticals, Inc. (8.85%), Legend Biotech Co. (6.04%), Blueprint Medicines Co. (6.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Viking Therapeutics stock? Short selling VKTX is an investing strategy that aims to generate trading profit from Viking Therapeutics as its price is falling. VKTX shares are trading up $3.79 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Viking Therapeutics? A short squeeze for Viking Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VKTX, which in turn drives the price of the stock up even further. How often is Viking Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VKTX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Intra-Cellular Therapies Short Squeeze Jazz Pharmaceuticals Short Squeeze Cytokinetics Short Squeeze Cerevel Therapeutics Short Squeeze Elanco Animal Health Short Squeeze Ionis Pharmaceuticals Short Squeeze Ascendis Pharma A/S Short Squeeze Apellis Pharmaceuticals Short Squeeze Legend Biotech Short Squeeze Blueprint Medicines Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VKTX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings